코스닥 이야기
Quickly browse recent reports in the selected category.
-
![[KOSDAQ Story] Contrary Thinking in the 1,500 KRW High Exchange Rate Era: Simmtech (222800) vs. MK Electron (033160) Export-Heavy IT Component Benefit Comparison](https://daily-stock.kr/stdaily/uploads/202606/gen_6a2fb1885bfb73.04110674.png)
[KOSDAQ Story] Contrary Thinking in the 1,500 KRW High Exchange Rate Era: Simmtech (222800) vs. MK Electron (033160) Export-Heavy IT Component Benefit Comparison
Daily Stock delivers an in-depth comparison of Simmtech and MK Electron, two KOSDAQ-listed IT component leaders with over 70% of revenues from exports, benefiting from the high USD/KRW exchange rate and the AI/HBM infrastructure boom.
-
![[KOSDAQ Story] Leeno Industrial (058470): Overhang Cleared After 730 Billion KRW Block Deal and Surging AI Testing Demand — Checking the Rebound Scenario](https://daily-stock.kr/stdaily/uploads/202606/gen_6a2e5fdbaa33d9.88742367.png)
[KOSDAQ Story] Leeno Industrial (058470): Overhang Cleared After 730 Billion KRW Block Deal and Surging AI Testing Demand — Checking the Rebound Scenario
DailyStock analyzes the successful 731.5 billion KRW block deal of Leeno Industrial (058470), clearing overhang risks. Coupled with high-margin AI testing demand and robust Q1 earnings, we examine the recovery potential.
-
KOSDAQ Hits 996 Mark Triggers 'Buying Sidecar', Game Stocks Surge as Crimson Desert Surpasses 6 Million Units Sold with H2 New Releases Pipeline
Despite global macro risks and geopolitical tensions, the KOSDAQ market staged a dramatic rebound, nearing the 1,000 threshold. Game stocks are leading the recovery based on strong console sales and major upcoming releases.
-
Kosdaq at 951 level; Chunbo (278280) Hits 52-Week Low... KRW 100 Billion CB Put Option Risk Drags Down Stock Despite Defense from Advanced Semiconductor Materials
Chunbo (278280) hit a 52-week low of KRW 37,250 during trading before closing at KRW 39,650 on June 10, 2026. Despite its semiconductor materials business holding up, massive CB put option risks are weighing heavily on the stock.
-
Analyzing KOSDAQ 150 PSR Valuations Amid a 'Sidecar' Rebound: Financials and Discrepancy Ratios for Fadu, Satrec Initiative, and Hyundai Movex
Amid a sharp market rebound triggered by a KOSDAQ sidecar, this analysis evaluates the PSR valuations and financial health of three key KOSDAQ 150 candidates: Fadu, Satrec Initiative, and Hyundai Movex.
-
![[KOSDAQ Story] HLB (028300) Clinical Trials & FDA Approval Timeline Amid Black Monday Crash: Critical Milestones for Liver Cancer in July and Cholangiocarcinoma in September](https://daily-stock.kr/stdaily/uploads/202606/gen_6a2676d12d4578.84092915.png)
[KOSDAQ Story] HLB (028300) Clinical Trials & FDA Approval Timeline Amid Black Monday Crash: Critical Milestones for Liver Cancer in July and Cholangiocarcinoma in September
HLB faces major commercialization milestones with upcoming FDA decisions: the PDUFA target date for its liver cancer therapy on July 23, 2026, and a decision on its cholangiocarcinoma treatment expected by September 27.